145 related articles for article (PubMed ID: 3569410)
1. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
[TBL] [Abstract][Full Text] [Related]
2. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
3. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
List SJ; Wreggett KA; Seeman P
J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
[TBL] [Abstract][Full Text] [Related]
4. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
5. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
Mulder TB; Grol CJ; Dijkstra D; Horn AS
Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
[TBL] [Abstract][Full Text] [Related]
6. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1987 Nov; 143(1):101-7. PubMed ID: 3121365
[TBL] [Abstract][Full Text] [Related]
7. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
List SJ; Seeman P
J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
[TBL] [Abstract][Full Text] [Related]
8. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
Lamont JS; Kula NS; Baldessarini RJ
Neuropharmacology; 1987 Jun; 26(6):637-9. PubMed ID: 3601010
[TBL] [Abstract][Full Text] [Related]
9. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
[TBL] [Abstract][Full Text] [Related]
10. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus.
Schoemaker H
Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
Watling KJ; Iversen LL
J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
[TBL] [Abstract][Full Text] [Related]
14. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
Closse A; Frick W; Markstein R; Maurer R; Nordmann R
J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
[TBL] [Abstract][Full Text] [Related]
15. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
Köhler C; Hall H; Ogren SO; Gawell L
Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
[TBL] [Abstract][Full Text] [Related]
16. D2- but not D3-dopamine receptors detected in the anterior pituitary.
Titeler M; Van Loon GR; Seeman P; Brown GM
Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
Williams M; Totaro JA
Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
[TBL] [Abstract][Full Text] [Related]
18. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
Van der Weide J; De Vries JB; Tepper PG; Krause DN; Dubocovich ML; Horn AS
Eur J Pharmacol; 1988 Mar; 147(2):249-58. PubMed ID: 3130270
[TBL] [Abstract][Full Text] [Related]
19. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
Bradbury AJ; Costall B; Naylor RJ
J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
[TBL] [Abstract][Full Text] [Related]
20. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
Osborne NN
Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]